Ulti_1170x120_5-11-20

Catalent Pharma Solutions

Perrigo, Catalent get FDA approval of Perrigo’s AB-rated generic of ProAir HFA

Perrigo, Catalent get FDA approval of Perrigo’s AB-rated generic of ProAir HFA

DUBLIN – Perrigo and its partner, Catalent Pharma Solutions, Wednesday announced that the U.S. Food and Drug Administration (FDA) has approved Perrigo’s abbreviated new drug application for generic albuterol sulfate inhalation aerosol, the first AB-rated generic version of ProAir HFA. Perrigo is launching a limited quantity of generic albuterol sulfate inhalation aerosol and, in collaboration